Mereo BioPharma Group PLC ADR (MREO) — Capital Reinvestment Ratio

Latest as of June 2021: 0.02x

Mereo BioPharma Group PLC ADR (MREO) has a Capital Reinvestment Ratio of 0.02x as of June 2021, meaning it reinvests 0% of its operating cash flow ($13.75 Million) in capital expenditures ($267.50K). See MREO equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$13.75 Million

USD

Capital Expenditures

$267.50K

USD

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for Mereo BioPharma Group PLC ADR (None–None)

Year-by-year Capital Reinvestment Ratio for Mereo BioPharma Group PLC ADR from None to None. For live market cap and broader valuation context, see MREO market cap overview.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow